Frontotemporal dementia (FTD): management
Evidence-based neurology checklist on frontotemporal dementia (ftd): management: Selective serotonin reuptake inhibitors (SSRIs): indications Disinhibition Stereotypy Depression Inappropriate sexual behaviour Treatment of emotional fluctuations Potential treatments Other management approaches…
Selective serotonin reuptake inhibitors (SSRIs): indications
- Disinhibition
- Stereotypy
- Depression
- Inappropriate sexual behaviour
Treatment of emotional fluctuations
Potential treatments
Other management approaches
Investigational treatments
References
- Mendez MF, Lauterbach EC, Sampson SM, ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci 2008; 20:130-149.
- Boxer AL, Boeve BF. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis Assoc Disord 2007; 21:S79-S87.
- Tsai RM, Boxer AL. Treatment of frontotemporal dementia. Curr Treat Options Neurol 2014; 16:319.
- Coleman KKL, Berry S, Cummings J, et al. Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial. Lancet Neurol 2025 (Online ahead of print).
